PCRX
Pacira BioSciences, Inc.
24.70$
+2.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.9% | 11.6% | 12.1% | 6.2% | 14.5% | 16.7% | 17.9% | 23.2% | 21.8% | 22.9% | 27.0% | 20.9% | |
| 5.1% | 4.6% | 4.7% | 4.8% | 3.9% | 4.6% | 4.6% | 5.3% | 13.7% | 11.2% | 11.2% | 12.5% | |
| 12.6% | 13.4% | 11.3% | 11.0% | 9.4% | 8.0% | 9.3% | 7.8% | 7.2% | 7.1% | 7.3% | 7.9% | |
| 12.6% | 13.4% | 11.4% | 13.1% | 9.7% | 13.2% | -17.5% | 10.1% | 8.6% | – | – | – | |
| -0.2% | -9.0% | 8.1% | -0.9% | -3.2% | -2.1% | -5.7% | -3.4% | -2.5% | -6.8% | -2.6% | -5.3% | |
| 11.1% | 16.6% | 8.9% | 6.7% | 4.3% | 2.4% | 8.8% | 8.5% | 4.5% | 2.2% | 1.5% | 2.1% | |
| -60.4% | -8.1% | -22.3% | -78.1% | 6.1% | -30.5% | -64.6% | -3.8% | -33.8% | 11.5% | -11.9% | 13.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | 1.0% | 0.4% | 0.5% | – | 0.4% | – | – | |
| 3.7% | 4.0% | 2.1% | 2.4% | 2.1% | 2.0% | 10.5% | 0.5% | 0.4% | 0.0% | -3.6% | -20.4% | |
| -0.7% | -0.6% | 0.0% | 75.3% | -0.1% | -0.1% | 29.2% | 67.2% | -64.1% | -26.8% | 10.9% | -29.8% | |
| 60.1% | 4.3% | 2.6% | 78.2% | 2.7% | 0.9% | 51.7% | 70.3% | -60.2% | -27.1% | 2.5% | -50.9% | |
| 12.6% | 7.8% | -7.6% | 6.3% | 23.2% | -12.9% | 5.1% | 89.7% | -72.2% | 7.3% | 17.6% | -16.3% | |
| 1.8% | -4.9% | 3.2% | -0.5% | 10.2% | 14.3% | 9.1% | 14.7% | 17.3% | 20.7% | 25.5% | 18.8% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.